Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01753037 · ClinicalTrials.gov registry record · NA
Effects of Androgen Administration on Inflammation in Normal Women
A NA study of Hyperandrogenism, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT01753037 is a NA study of Hyperandrogenism that has completed, run by Mayo Clinic. The registered enrollment target is 25 participants, below the 33-participant average among 3 other Hyperandrogenism trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01753037, a NA study of Hyperandrogenism, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The hypothesis of this study is that DHEA administration to increase male hormone in healthy normal-weight young women to levels present in women with Polycystic Ovary Syndrome will cause an inflammatory response in white blood cells in the fasting state, and in response to glucose ingestion.
Conditions Studied
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Dehydroepiandrosterone (DHEA)
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2006-12 |
| Est. Completion | 2010-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01753037
The ClinicalTrials.gov registry entry for NCT01753037 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 33-participant average among 3 other Hyperandrogenism trials with a reported enrollment target (24% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hyperandrogenism appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01753037 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT01753037 about?
NCT01753037 is a clinical study titled "Effects of Androgen Administration on Inflammation in Normal Women". The hypothesis of this study is that DHEA administration to increase male hormone in healthy normal-weight young women to levels present in women with Polycystic Ovary Syndrome will cause an inflammatory response in white blood cells in the fasting state, and in response to glucose ingestion.
What is the current status of trial NCT01753037?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2006-12. Estimated completion is 2010-04.
What conditions does trial NCT01753037 study?
This clinical trial studies the following conditions: Hyperandrogenism.
What interventions are being tested in trial NCT01753037?
The interventions under investigation include: Placebo (OTHER), Dehydroepiandrosterone (DHEA) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01753037?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01753037 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hyperandrogenism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Does Spironolactone Normalize Sleep-wake Luteinizing Hormone Pulse Frequency in Pubertal Girls With Hyperandrogenism?
RECRUITING · Early Phase 1
-
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
RECRUITING · Early Phase 1
-
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.